TN2009000258A1 - Freeze-dried injectable pharmaceutical combination of semisynthetic vinca alkaloids and carbohydrate stable at room temperature. - Google Patents

Freeze-dried injectable pharmaceutical combination of semisynthetic vinca alkaloids and carbohydrate stable at room temperature.

Info

Publication number
TN2009000258A1
TN2009000258A1 TNP2009000258A TN2009000258A TN2009000258A1 TN 2009000258 A1 TN2009000258 A1 TN 2009000258A1 TN P2009000258 A TNP2009000258 A TN P2009000258A TN 2009000258 A TN2009000258 A TN 2009000258A TN 2009000258 A1 TN2009000258 A1 TN 2009000258A1
Authority
TN
Tunisia
Prior art keywords
room temperature
freeze
pharmaceutical combination
vinca alkaloids
injectable pharmaceutical
Prior art date
Application number
TNP2009000258A
Other languages
English (en)
Inventor
Elie Leverd
Joel Bougaret
Marie-Dominique Ibarra
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38293420&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TN2009000258(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pf Medicament filed Critical Pf Medicament
Publication of TN2009000258A1 publication Critical patent/TN2009000258A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
TNP2009000258A 2006-12-29 2009-06-23 Freeze-dried injectable pharmaceutical combination of semisynthetic vinca alkaloids and carbohydrate stable at room temperature. TN2009000258A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0656044A FR2910812B1 (fr) 2006-12-29 2006-12-29 Compositions pharmaceutiques injectables lyophilisees de derives hemi-synthetiques d'alcaloide de vinca stables a temperature ambiante
PCT/EP2007/064612 WO2008080968A1 (fr) 2006-12-29 2007-12-28 Combinaison pharmaceutique d'alcaloïdes de la pervenche semi-synthétiques et de carbohydrate injectable lyophilisée stable à température ambiante

Publications (1)

Publication Number Publication Date
TN2009000258A1 true TN2009000258A1 (en) 2010-10-18

Family

ID=38293420

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2009000258A TN2009000258A1 (en) 2006-12-29 2009-06-23 Freeze-dried injectable pharmaceutical combination of semisynthetic vinca alkaloids and carbohydrate stable at room temperature.

Country Status (24)

Country Link
US (1) US8304424B2 (fr)
EP (1) EP2120934B1 (fr)
JP (1) JP2010514737A (fr)
KR (1) KR20090097883A (fr)
CN (1) CN101534821B (fr)
AR (1) AR064715A1 (fr)
AU (1) AU2007341231B2 (fr)
BR (1) BRPI0722076A2 (fr)
CA (1) CA2673232A1 (fr)
CL (1) CL2007003838A1 (fr)
FR (1) FR2910812B1 (fr)
HK (1) HK1130439A1 (fr)
IL (1) IL199556A (fr)
MA (1) MA30892B1 (fr)
MX (1) MX2009006949A (fr)
NO (1) NO20092726L (fr)
NZ (1) NZ576583A (fr)
RU (1) RU2449791C2 (fr)
SA (1) SA07280720B1 (fr)
TN (1) TN2009000258A1 (fr)
TW (1) TWI415631B (fr)
UA (1) UA96977C2 (fr)
WO (1) WO2008080968A1 (fr)
ZA (1) ZA200903115B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102151249A (zh) * 2010-02-11 2011-08-17 石药集团中奇制药技术（石家庄）有限公司 一种长春氟宁的药用组合物
JO3112B1 (ar) * 2010-03-29 2017-09-20 Ferring Bv تركيبة دوائية سريعة التحلل
CN102772373B (zh) * 2011-05-11 2015-09-02 石药集团中奇制药技术（石家庄）有限公司 一种注射用酒石酸长春瑞滨粉针剂及其制备方法
CA3110527A1 (fr) * 2018-08-31 2020-03-05 FUJIFILM Irvine Scientific, Inc. Systeme de ventilation pour appareil de melange

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1170152B (it) * 1982-07-19 1987-06-03 Lilly Co Eli Miglioramenti a o riguardanti formulazioni di vinca-alcaloidi
US4619935A (en) * 1983-03-17 1986-10-28 Eli Lilly And Company Stable oncolytic formulations
US4923876A (en) * 1988-04-18 1990-05-08 Cetus Corporation Vinca alkaloid pharmaceutical compositions
CA2013600A1 (fr) * 1989-04-04 1990-10-04 Michael J. Pikal Formules pharmaceutiques
US6143276A (en) * 1997-03-21 2000-11-07 Imarx Pharmaceutical Corp. Methods for delivering bioactive agents to regions of elevated temperatures
FR2761990B1 (fr) * 1997-04-10 1999-06-25 Pf Medicament Derives halogenes antimitotiques d'alcaloides de vinca
PL205936B1 (pl) * 2002-02-22 2010-06-30 Schering Corp Farmaceutyczny preparat zawierający termozolomid oraz sposób jego wytwarzania
FR2863891B1 (fr) * 2003-12-23 2006-03-24 Pf Medicament Composition pharmaceutique de vinflunine destinee a une administration parentale, procede de preparation et utilisation
EP4218730B1 (fr) * 2004-05-03 2023-11-01 Ipsen Biopharm Ltd. Liposomes utiles pour l'administration de médicaments
PE20061107A1 (es) * 2005-03-14 2006-12-08 Wyeth Corp Composiciones de tigeciclina y metodos para su preparacion

Also Published As

Publication number Publication date
HK1130439A1 (en) 2009-12-31
CA2673232A1 (fr) 2008-07-10
US20100087473A1 (en) 2010-04-08
SA07280720B1 (ar) 2012-02-07
FR2910812A1 (fr) 2008-07-04
IL199556A (en) 2014-09-30
JP2010514737A (ja) 2010-05-06
AR064715A1 (es) 2009-04-22
WO2008080968A1 (fr) 2008-07-10
US8304424B2 (en) 2012-11-06
RU2009128327A (ru) 2011-02-10
CN101534821A (zh) 2009-09-16
TW200833369A (en) 2008-08-16
CL2007003838A1 (es) 2008-07-04
KR20090097883A (ko) 2009-09-16
RU2449791C2 (ru) 2012-05-10
FR2910812B1 (fr) 2009-03-20
AU2007341231A1 (en) 2008-07-10
NO20092726L (no) 2009-07-20
ZA200903115B (en) 2010-04-28
MX2009006949A (es) 2009-07-14
MA30892B1 (fr) 2009-11-02
NZ576583A (en) 2012-01-12
CN101534821B (zh) 2012-01-25
AU2007341231B2 (en) 2013-03-21
UA96977C2 (ru) 2011-12-26
EP2120934B1 (fr) 2014-05-07
TWI415631B (zh) 2013-11-21
EP2120934A1 (fr) 2009-11-25
BRPI0722076A2 (pt) 2014-04-08

Similar Documents

Publication Publication Date Title
TNSN08326A1 (en) Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
WO2006119498A3 (fr) Compositions pharmaceutiques avec liberation synchronisee de l'agent solubilisant
WO2006076620A3 (fr) Compositions pharmaceutiques de bendamustine
WO2007089745A3 (fr) Nouveaux composés à indice thérapeutique élevé
IL189187A (en) Polymeric couplings of a252-k and their history, their pharmaceutical preparations and their uses
WO2008024978A3 (fr) Dérivés de benzène, de pyridine et de pyridazine
DOP2009000135A (es) Derivados de 2,3-dihidroimidazo [1,2-c] quinazolina sustituídos de utilidad en el tratamiento de trastornos hiperproliferativos y enfermedades asociadas con la angiogénesis
WO2006028525A3 (fr) Composes heterocycliques [3.2.0] et leurs procedes d'utilisation
BRPI0816798A2 (pt) composto, composição farmacêutica, métodos para inibir a ação do glicogênio sintase cinase-3, e para tratar, prevenir ou melhorar uma doença, uso de um composto, e, artigo de fabricação
TN2009000258A1 (en) Freeze-dried injectable pharmaceutical combination of semisynthetic vinca alkaloids and carbohydrate stable at room temperature.
MY149854A (en) Novel aminoalcohol-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
FR2911137B1 (fr) Nouveaux derives de 2,4-dianilinopyrimides, leur preparation a titre de medicaments, compositions pharmaceutiques et notamment comme inhibiteurs de ikk
TW200740764A (en) Pyrazolone derivatives
TNSN07337A1 (en) Pharmaceutical composition comprising an indolylmaleimide derivative
WO2007072092A8 (fr) Nouveaux derives de phenanthridine utilises comme antagonistes de la bradykinine
EP2219640A4 (fr) Composition pharmaceutique lyophilisée présentant un temps de reconstitution amélioré et contenant des dérivés de taxane et son procédé de fabrication
BRPI0506535A (pt) pirroles bis-indole úteis como agentes anti-microbiais
WO2008024970A3 (fr) Dérivés de benzène, de pyridine et de pyridazine
PT1975158E (pt) Novos derivados de pirrole com actividade inibidora de histona desacetilase
CY1110787T1 (el) Νεα μορφινικα παραγωγα
TH109864B (th) องค์ประกอบทางเภสัชกรรมแบบฉีดได้ที่ถูกทำแห้งแบบเยือกแข็งของอนุพันธ์กึ่งสังเคราะห์ของวินคา อัลคาลอยด์ ซึ่งเสถียรที่อุณภูมิห้อง
TH109864A (th) องค์ประกอบทางเภสัชกรรมแบบฉีดได้ที่ถูกทำแห้งแบบเยือกแข็งของอนุพันธ์กึ่งสังเคราะห์ของวินคา อัลคาลอยด์ ซึ่งเสถียรที่อุณภูมิห้อง
WO2006107806A3 (fr) Compositions de stannsoporfine et administration
FR2888239B1 (fr) Nouveaux derives de 2,4-dianilinopyrimidines, leur preparation, a titre de medicaments, compositions pharmaceutiques et notamment comme inhibiteurs de ikk
WO2007114946A3 (fr) Lieurs sensibles aux acides destinés à l'administration de médicaments